Previous 10 |
Atossa Genetics (NASDAQ: ATOS ) +29% on updating the status of the pre-menopausal, estrogen-receptor positive (ER+) breast cancer patient who received preoperative oral Endoxifen therapy under an FDA-approved “expanded access” program. More news on: Atossa Genetics, ...
News, Short Squeeze, Breakout and More Instantly...
Blonder Tongue Laboratories Inc. Company Name:
BDR Stock Symbol:
NYSE Market:
Blonder Tongue Laboratories Inc. Website:
OLD BRIDGE, NJ / ACCESSWIRE / June 24, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR ) today announced its delisting from the NYSE American and commencement of trading on the OTCQB. As previously disclosed, Blonder Tongue Laboratories, Inc. (the "Company") received written ...
Offering Broadcasters, Satellite and Cable Operators a Migration Path to Ultra Low Bandwidth Video Delivery OLD BRIDGE, NJ / ACCESSWIRE / June 8, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR), a leading US-based designer and manufacturer of video and data transmission t...
New RMDA 1000 offers expanded Bandwidth and Flexibility OLD BRIDGE, NJ / ACCESSWIRE / May 23, 2022 / Blonder Tongue Laboratories, Inc. (NYSE American: BDR ) today announced the release of its newest Rack-Mount Distribution Amplifier (RMDA), the RMDA 1000-42P , expanding on its best-s...